Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT00541255Completed

A Long-Term Examination of Asthma From Childhood Through Adolescence

Role: lead

NCT04729530Not ApplicableCompleted

The Effect of Dyson Air Purifier in Improving Asthma Control

Role: collaborator

NCT03763630Phase 2Completed

MAPS & ITEC Cohorts: 6-8 Years Follow-up

Role: collaborator

NCT03509428Not ApplicableUnknown

The Wessex Fit-4-Cancer Surgery Trial

Role: collaborator

NCT03534765Unknown

Frailty and Sarcopenia Outcomes in Emergency General Surgery

Role: collaborator

All 5 trials loaded